Skip to main content
. 2020 Apr 6;2020:2367505. doi: 10.1155/2020/2367505

Table 1.

Baseline characteristics of study population.

Groups TBLB group R-EBUS-TBLB group t/χ2 value P value
Particients 60 61
Age ± 2SD (years) 55.8 ± 12.5 55.4 ± 11.5 1.168 0.243
Male/female 38/22 36/25 0.237 0.626
Immunodeficiency
 Hematological malignancy 34 (56.7) 36 (59.0) 0.068 0.794
Lesion location n%
 Lower lobe 27 (45.0) 33 (54.1) 2.524 0.283
 Right upper lobe 16 (26.7) 18 (29.5)
 Left upper lobe 17 (28.3) 10 (16.4)
Leision size
 ≤3 cm 19 (31.7) 18 (29.5) 0.066 0.797
 >3 cm 41 (68.3) 43 (70.5)
Distance from the chest wall
 ≤3 cm 22 (36.7) 28 (45.9) 1.064 0.302
 >3 cm 38 (63.3) 33 (54.1)
CT findings
 Nodule or cavitation 19 (31.7) 28 (45.9) 2.720 0.257
 Confluent or patchy consolidation 29 (48.3) 22 (36.1)
 GGO 12 (20.0) 11 (18.0)
Complications
 Mild bleeding 2 (3.3) 1 (1.6) 0.359 0.549
 Pneumothorax 2 (3.3) 1 (1.6) 0.356 0.551
Final diagnosis
 Bacteria (mycobacteria excluded) 30 (50) 33 (54.1)
 Virus 12 (20) 11 (18)
 Fungus 18 (30) 21 (34.4)
 Atypical pathogen 6 (10) 7 (11.5)
 MTBC 9 (15) 10 (16.4)
Positivity of mNGS 36 (60.0) 48 (78.7) 4.977 0.026

GGO, ground-glass opacity. MTBC, mycobacterium tuberculosis complex. Data are presented as no. (%) or mean ± SD unless otherwise indicated.